来自MSN1 个月
MSD’s HPV vaccine gains China NMPA’s expanded approval for males
The China National Medical Products Administration (NMPA ... Recombinant] for use in males aged nine to 26 years. It is indicated to prevent certain human papillomavirus (HPV)-related cancers ...